NXL
Nexalin Technology, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$5.06
−5.60%Next report
Analyst consensus
- Next report date
- Dec 2, 2026
- EPS estimate
- -$2.70
- Revenue estimate
- $90.0K
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$0.11
- EPS estimate
- -$0.10
- Revenue actual
- $12.2K
- Revenue estimate
- $90.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -9.2%
- Revenue beats (12Q)
- 2
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 2, 2026